ID   K1C12_HUMAN             Reviewed;         494 AA.
AC   Q99456; B2R9E0;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1997, sequence version 1.
DT   28-JUN-2023, entry version 186.
DE   RecName: Full=Keratin, type I cytoskeletal 12;
DE   AltName: Full=Cytokeratin-12;
DE            Short=CK-12;
DE   AltName: Full=Keratin-12;
DE            Short=K12;
GN   Name=KRT12;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Cornea;
RX   PubMed=8759347;
RA   Nishida K., Adachi W., Shimizu-Matsumoto A., Kinoshita S., Mizuno K.,
RA   Matsubara K., Okubo K.;
RT   "A gene expression profile of human corneal epithelium and the isolation of
RT   human keratin 12 cDNA.";
RL   Invest. Ophthalmol. Vis. Sci. 37:1800-1809(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS MECD1 GLY-135; ILE-135;
RP   ARG-140 AND ASP-429.
RX   PubMed=9399908; DOI=10.1086/301650;
RA   Nishida K., Honma Y., Dota A., Kawasaki S., Adachi W., Nakamura T.,
RA   Quantock A.J., Hosotani H., Yamamoto S., Okada M., Shimomura Y.,
RA   Kinoshita S.;
RT   "Isolation and chromosomal localization of a cornea-specific human keratin
RT   12 gene and detection of four mutations in Meesmann corneal epithelial
RT   dystrophy.";
RL   Am. J. Hum. Genet. 61:1268-1275(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], VARIANTS MECD1 THR-129 AND THR-135, AND VARIANT
RP   TRP-20.
RX   PubMed=10644419; DOI=10.1006/exer.1999.0769;
RA   Corden L.D., Swensson O., Swensson B., Smith F.J.D., Rochels R., Uitto J.,
RA   McLean W.H.I.;
RT   "Molecular genetics of Meesmann's corneal dystrophy: ancestral and novel
RT   mutations in keratin 12 (K12) and complete sequence of the human KRT12
RT   gene.";
RL   Exp. Eye Res. 70:41-49(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   PROTEIN SEQUENCE OF 21-31.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A., Thomas G.R.,
RA   Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass spectrometric
RT   identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8]
RP   FUNCTION, TISSUE SPECIFICITY, AND CHARACTERIZATION OF VARIANT MECD1
RP   PRO-132.
RX   PubMed=26758872; DOI=10.1093/hmg/ddw001;
RA   Allen E.H., Courtney D.G., Atkinson S.D., Moore J.E., Mairs L.,
RA   Poulsen E.T., Schiroli D., Maurizi E., Cole C., Hickerson R.P., James J.,
RA   Murgatroyd H., Smith F.J., MacEwen C., Enghild J.J., Nesbit M.A.,
RA   Leslie Pedrioli D.M., McLean W.H., Moore C.B.;
RT   "Keratin 12 missense mutation induces the unfolded protein response and
RT   apoptosis in Meesmann epithelial corneal dystrophy.";
RL   Hum. Mol. Genet. 25:1176-1191(2016).
RN   [9]
RP   VARIANTS MECD1 THR-135 AND LEU-143.
RX   PubMed=9171831; DOI=10.1038/ng0697-184;
RA   Irvine A.D., Corden L.D., Swensson O., Swensson B., Moore J.E.,
RA   Frazer D.G., Smith F.J.D., Knowlton R.G., Christophers E., Rochels R.,
RA   Uitto J., McLean W.H.I.;
RT   "Mutations in cornea-specific keratin K3 or K12 genes cause Meesmann's
RT   corneal dystrophy.";
RL   Nat. Genet. 16:184-187(1997).
RN   [10]
RP   VARIANT MECD1 VAL-426.
RX   PubMed=10612503; DOI=10.1016/s0002-9394(99)00317-7;
RA   Coleman C.M., Hannush S., Covello S.P., Smith F.J., Uitto J., McLean W.H.;
RT   "A novel mutation in the helix termination motif of keratin K12 in a US
RT   family with Meesmann corneal dystrophy.";
RL   Am. J. Ophthalmol. 128:687-691(1999).
RN   [11]
RP   VARIANT MECD1 PRO-130.
RX   PubMed=10781519; DOI=10.1136/bjo.84.5.527;
RA   Corden L.D., Swensson O., Swensson B., Rochels R., Wannke B., Thiel H.J.,
RA   McLean W.H.I.;
RT   "A novel keratin 12 mutation in a German kindred with Meesmann's corneal
RT   dystrophy.";
RL   Br. J. Ophthalmol. 84:527-530(2000).
RN   [12]
RP   VARIANT MECD1 PRO-137.
RX   PubMed=12543196; DOI=10.1016/s0021-5155(02)00563-4;
RA   Takahashi K., Takahashi K., Murakami A., Okisaka S., Kimura T., Kanai A.;
RT   "Heterozygous Ala137Pro mutation in keratin 12 gene found in Japanese with
RT   Meesmann's corneal dystrophy.";
RL   Jpn. J. Ophthalmol. 46:673-674(2002).
RN   [13]
RP   VARIANTS MECD1 SER-135 AND ILE-SER-ASN-LEU-GLU-ALA-GLN-LEU-LEU-399 INS.
RX   PubMed=15148206; DOI=10.1136/bjo.2003.032870;
RA   Yoon M.K., Warren J.F., Holsclaw D.S., Gritz D.C., Margolis T.P.;
RT   "A novel arginine substitution mutation in 1A domain and a novel 27 bp
RT   insertion mutation in 2B domain of keratin 12 gene associated with
RT   Meesmann's corneal dystrophy.";
RL   Br. J. Ophthalmol. 88:752-756(2004).
RN   [14]
RP   VARIANT MECD1 CYS-429.
RX   PubMed=16227835; DOI=10.1097/01.ico.0000159732.29930.26;
RA   Chen Y.T., Tseng S.H., Chao S.C.;
RT   "Novel mutations in the helix termination motif of keratin 3 and keratin 12
RT   in 2 Taiwanese families with Meesmann corneal dystrophy.";
RL   Cornea 24:928-932(2005).
RN   [15]
RP   VARIANTS MECD1 THR-129 AND SER-426.
RX   PubMed=16352477; DOI=10.1080/13816810500374391;
RA   Nichini O., Manzi V., Munier F.L., Schorderet D.F.;
RT   "Meesmann corneal dystrophy (MECD): report of 2 families and a novel
RT   mutation in the cornea specific keratin 12 (KRT12) gene.";
RL   Ophthalmic Genet. 26:169-173(2005).
RN   [16]
RP   VARIANT MECD1 PRO-430.
RX   PubMed=17653038;
RA   Sullivan L.S., Baylin E.B., Font R., Daiger S.P., Pepose J.S., Clinch T.E.,
RA   Nakamura H., Zhao X.C., Yee R.W.;
RT   "A novel mutation of the Keratin 12 gene responsible for a severe phenotype
RT   of Meesmann's corneal dystrophy.";
RL   Mol. Vis. 13:975-980(2007).
RN   [17]
RP   VARIANTS SER-15 AND TRP-20, AND VARIANT MECD1 LEU-143.
RX   PubMed=18245975; DOI=10.1097/ico.0b013e31815652fd;
RA   Nielsen K., Orntoft T., Hjortdal J., Rasmussen T., Ehlers N.;
RT   "A novel mutation as the basis for asymptomatic meesmann dystrophy in a
RT   Danish family.";
RL   Cornea 27:100-102(2008).
RN   [18]
RP   VARIANT MECD1 ARG-433.
RX   PubMed=18661274; DOI=10.1007/s10384-007-0518-2;
RA   Seto T., Fujiki K., Kishishita H., Fujimaki T., Murakami A., Kanai A.;
RT   "A novel mutation in the cornea-specific keratin 12 gene in Meesmann
RT   corneal dystrophy.";
RL   Jpn. J. Ophthalmol. 52:224-226(2008).
RN   [19]
RP   VARIANT SER-15, AND VARIANT MECD1 VAL-129.
RX   PubMed=20577595;
RA   Clausen I., Duncker G.I., Grunauer-Kloevekorn C.;
RT   "Identification of a novel mutation in the cornea specific keratin 12 gene
RT   causing Meesmann's corneal dystrophy in a German family.";
RL   Mol. Vis. 16:954-960(2010).
RN   [20]
RP   VARIANT MECD1 PRO-132.
RX   PubMed=23222558; DOI=10.1038/eye.2012.261;
RA   Hassan H., Thaung C., Ebenezer N.D., Larkin G., Hardcastle A.J., Tuft S.J.;
RT   "Severe Meesmann's epithelial corneal dystrophy phenotype due to a missense
RT   mutation in the helix-initiation motif of keratin 12.";
RL   Eye 27:367-373(2013).
RN   [21]
RP   VARIANT MECD1 GLN-140.
RX   PubMed=24099278; DOI=10.1016/j.ajo.2013.08.008;
RA   Ogasawara M., Matsumoto Y., Hayashi T., Ohno K., Yamada H., Kawakita T.,
RA   Dogru M., Shimazaki J., Tsubota K., Tsuneoka H.;
RT   "KRT12 mutations and in vivo confocal microscopy in two Japanese families
RT   with Meesmann corneal dystrophy.";
RL   Am. J. Ophthalmol. 157:93-102(2014).
RN   [22]
RP   VARIANTS MECD1 VAL-132 AND ASN-248.
RX   PubMed=30535821; DOI=10.1007/s10384-018-00643-6;
RA   Nishino T., Kobayashi A., Mori N., Masaki T., Yokogawa H., Fujiki K.,
RA   Yanagawa A., Murakami A., Sugiyama K.;
RT   "In vivo histology and p.L132V mutation in KRT12 gene in Japanese patients
RT   with Meesmann corneal dystrophy.";
RL   Jpn. J. Ophthalmol. 63:46-55(2019).
CC   -!- FUNCTION: Involved in corneal epithelium organization, integrity and
CC       corneal keratin expression. {ECO:0000269|PubMed:26758872}.
CC   -!- SUBUNIT: Heterotetramer of two type I and two type II keratins.
CC       Keratin-3 associates with keratin-12.
CC   -!- TISSUE SPECIFICITY: Expressed in the corneal epithelium (at protein
CC       level). {ECO:0000269|PubMed:26758872, ECO:0000269|PubMed:8759347}.
CC   -!- DISEASE: Corneal dystrophy, Meesmann 1 (MECD1) [MIM:122100]: A form of
CC       Meesmann corneal dystrophy, a corneal disease characterized by
CC       fragility of the anterior corneal epithelium. Histological examination
CC       shows a disorganized and thickened epithelium with widespread
CC       cytoplasmic vacuolation and numerous small, round, debris-laden
CC       intraepithelial cysts. Patients are usually asymptomatic until
CC       adulthood when rupture of the corneal microcysts may cause erosions,
CC       producing clinical symptoms such as photophobia, contact lens
CC       intolerance and intermittent diminution of visual acuity. Rarely,
CC       subepithelial scarring causes irregular corneal astigmatism and
CC       permanent visual impairment. MECD1 inheritance is autosomal dominant.
CC       {ECO:0000269|PubMed:10612503, ECO:0000269|PubMed:10644419,
CC       ECO:0000269|PubMed:10781519, ECO:0000269|PubMed:12543196,
CC       ECO:0000269|PubMed:15148206, ECO:0000269|PubMed:16227835,
CC       ECO:0000269|PubMed:16352477, ECO:0000269|PubMed:17653038,
CC       ECO:0000269|PubMed:18245975, ECO:0000269|PubMed:18661274,
CC       ECO:0000269|PubMed:20577595, ECO:0000269|PubMed:23222558,
CC       ECO:0000269|PubMed:24099278, ECO:0000269|PubMed:26758872,
CC       ECO:0000269|PubMed:30535821, ECO:0000269|PubMed:9171831,
CC       ECO:0000269|PubMed:9399908}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: There are two types of cytoskeletal and microfibrillar
CC       keratin: I (acidic; 40-55 kDa) and II (neutral to basic; 56-70 kDa).
CC   -!- SIMILARITY: Belongs to the intermediate filament family.
CC       {ECO:0000255|PROSITE-ProRule:PRU01188}.
CC   -!- WEB RESOURCE: Name=Human Intermediate Filament Mutation Database;
CC       URL="http://www.interfil.org";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Keratin-12 entry;
CC       URL="https://en.wikipedia.org/wiki/Keratin_12";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D78367; BAA11376.1; -; mRNA.
DR   EMBL; AB007119; BAA25063.1; -; Genomic_DNA.
DR   EMBL; AF137286; AAF61432.1; -; Genomic_DNA.
DR   EMBL; AK313747; BAG36487.1; -; mRNA.
DR   EMBL; CH471152; EAW60685.1; -; Genomic_DNA.
DR   CCDS; CCDS11378.1; -.
DR   RefSeq; NP_000214.1; NM_000223.3.
DR   AlphaFoldDB; Q99456; -.
DR   SMR; Q99456; -.
DR   BioGRID; 110057; 5.
DR   STRING; 9606.ENSP00000251643; -.
DR   DrugBank; DB11157; Anthralin.
DR   DrugBank; DB00400; Griseofulvin.
DR   GlyGen; Q99456; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q99456; -.
DR   PhosphoSitePlus; Q99456; -.
DR   SwissPalm; Q99456; -.
DR   BioMuta; KRT12; -.
DR   DMDM; 2497269; -.
DR   jPOST; Q99456; -.
DR   MassIVE; Q99456; -.
DR   PaxDb; Q99456; -.
DR   PeptideAtlas; Q99456; -.
DR   PRIDE; Q99456; -.
DR   ProteomicsDB; 78275; -.
DR   Antibodypedia; 55294; 266 antibodies from 33 providers.
DR   DNASU; 3859; -.
DR   Ensembl; ENST00000251643.5; ENSP00000251643.4; ENSG00000187242.6.
DR   Ensembl; ENST00000572470.2; ENSP00000459559.2; ENSG00000263243.2.
DR   GeneID; 3859; -.
DR   KEGG; hsa:3859; -.
DR   MANE-Select; ENST00000251643.5; ENSP00000251643.4; NM_000223.4; NP_000214.1.
DR   UCSC; uc002hvk.3; human.
DR   AGR; HGNC:6414; -.
DR   CTD; 3859; -.
DR   DisGeNET; 3859; -.
DR   GeneCards; KRT12; -.
DR   HGNC; HGNC:6414; KRT12.
DR   HPA; ENSG00000187242; Tissue enhanced (intestine).
DR   MalaCards; KRT12; -.
DR   MIM; 122100; phenotype.
DR   MIM; 601687; gene.
DR   neXtProt; NX_Q99456; -.
DR   OpenTargets; ENSG00000187242; -.
DR   Orphanet; 98954; Meesmann corneal dystrophy.
DR   PharmGKB; PA30201; -.
DR   VEuPathDB; HostDB:ENSG00000187242; -.
DR   eggNOG; ENOG502QTM6; Eukaryota.
DR   GeneTree; ENSGT00940000159382; -.
DR   HOGENOM; CLU_012560_8_3_1; -.
DR   InParanoid; Q99456; -.
DR   OMA; EHQNADH; -.
DR   OrthoDB; 4640531at2759; -.
DR   PhylomeDB; Q99456; -.
DR   TreeFam; TF332742; -.
DR   PathwayCommons; Q99456; -.
DR   Reactome; R-HSA-6805567; Keratinization.
DR   Reactome; R-HSA-6809371; Formation of the cornified envelope.
DR   BioGRID-ORCS; 3859; 12 hits in 1153 CRISPR screens.
DR   ChiTaRS; KRT12; human.
DR   GeneWiki; Keratin_12; -.
DR   GenomeRNAi; 3859; -.
DR   Pharos; Q99456; Tbio.
DR   PRO; PR:Q99456; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; Q99456; protein.
DR   Bgee; ENSG00000187242; Expressed in mucosa of transverse colon and 57 other tissues.
DR   ExpressionAtlas; Q99456; baseline and differential.
DR   Genevisible; Q99456; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005882; C:intermediate filament; IEA:UniProtKB-KW.
DR   GO; GO:0005198; F:structural molecule activity; NAS:ProtInc.
DR   GO; GO:0061303; P:cornea development in camera-type eye; IMP:UniProtKB.
DR   GO; GO:0030855; P:epithelial cell differentiation; IBA:GO_Central.
DR   GO; GO:0045109; P:intermediate filament organization; IBA:GO_Central.
DR   GO; GO:0002009; P:morphogenesis of an epithelium; IMP:UniProtKB.
DR   GO; GO:0007601; P:visual perception; TAS:ProtInc.
DR   Gene3D; 1.20.5.170; -; 1.
DR   Gene3D; 1.20.5.500; Single helix bin; 1.
DR   Gene3D; 1.20.5.1160; Vasodilator-stimulated phosphoprotein; 1.
DR   InterPro; IPR018039; IF_conserved.
DR   InterPro; IPR039008; IF_rod_dom.
DR   InterPro; IPR002957; Keratin_I.
DR   PANTHER; PTHR23239; INTERMEDIATE FILAMENT; 1.
DR   PANTHER; PTHR23239:SF369; KERATIN, TYPE I CYTOSKELETAL 12; 1.
DR   Pfam; PF00038; Filament; 1.
DR   PRINTS; PR01248; TYPE1KERATIN.
DR   SMART; SM01391; Filament; 1.
DR   SUPFAM; SSF64593; Intermediate filament protein, coiled coil region; 2.
DR   PROSITE; PS00226; IF_ROD_1; 1.
DR   PROSITE; PS51842; IF_ROD_2; 1.
PE   1: Evidence at protein level;
KW   Coiled coil; Corneal dystrophy; Direct protein sequencing; Disease variant;
KW   Intermediate filament; Keratin; Reference proteome.
FT   CHAIN           1..494
FT                   /note="Keratin, type I cytoskeletal 12"
FT                   /id="PRO_0000063644"
FT   DOMAIN          125..440
FT                   /note="IF rod"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01188"
FT   REGION          1..124
FT                   /note="Head"
FT   REGION          1..32
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          125..160
FT                   /note="Coil 1A"
FT   REGION          164..182
FT                   /note="Linker 1"
FT   REGION          183..274
FT                   /note="Coil 1B"
FT   REGION          275..297
FT                   /note="Linker 12"
FT   REGION          298..435
FT                   /note="Coil 2"
FT   REGION          436..494
FT                   /note="Tail"
FT   REGION          446..468
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1..31
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        447..461
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   VARIANT         15
FT                   /note="P -> S (in dbSNP:rs11650915)"
FT                   /evidence="ECO:0000269|PubMed:18245975,
FT                   ECO:0000269|PubMed:20577595"
FT                   /id="VAR_049783"
FT   VARIANT         20
FT                   /note="R -> W (in dbSNP:rs17566772)"
FT                   /evidence="ECO:0000269|PubMed:10644419,
FT                   ECO:0000269|PubMed:18245975"
FT                   /id="VAR_009547"
FT   VARIANT         129
FT                   /note="M -> T (in MECD1; dbSNP:rs28936695)"
FT                   /evidence="ECO:0000269|PubMed:10644419,
FT                   ECO:0000269|PubMed:16352477"
FT                   /id="VAR_013126"
FT   VARIANT         129
FT                   /note="M -> V (in MECD1; dbSNP:rs267607387)"
FT                   /evidence="ECO:0000269|PubMed:20577595"
FT                   /id="VAR_072069"
FT   VARIANT         130
FT                   /note="Q -> P (in MECD1; dbSNP:rs58864803)"
FT                   /evidence="ECO:0000269|PubMed:10781519"
FT                   /id="VAR_013127"
FT   VARIANT         132
FT                   /note="L -> P (in MECD1; increased expression of keratins
FT                   KRT5, KRT6, KRT14 and KRT16 and decreased expression of
FT                   KRT12 in the corneal epithelium; increased expression of
FT                   DDIT3/CHOP and CASP12 in the corneal epithelium indicative
FT                   of up-regulation of the unfolded protein response.;
FT                   dbSNP:rs886038212)"
FT                   /evidence="ECO:0000269|PubMed:23222558,
FT                   ECO:0000269|PubMed:26758872"
FT                   /id="VAR_072070"
FT   VARIANT         132
FT                   /note="L -> V (in MECD1)"
FT                   /evidence="ECO:0000269|PubMed:30535821"
FT                   /id="VAR_083313"
FT   VARIANT         135
FT                   /note="R -> G (in MECD1; dbSNP:rs58410481)"
FT                   /evidence="ECO:0000269|PubMed:9399908"
FT                   /id="VAR_008526"
FT   VARIANT         135
FT                   /note="R -> I (in MECD1; dbSNP:rs57218384)"
FT                   /evidence="ECO:0000269|PubMed:9399908"
FT                   /id="VAR_008525"
FT   VARIANT         135
FT                   /note="R -> S (in MECD1; dbSNP:rs61282718)"
FT                   /evidence="ECO:0000269|PubMed:15148206"
FT                   /id="VAR_031394"
FT   VARIANT         135
FT                   /note="R -> T (in MECD1; dbSNP:rs57218384)"
FT                   /evidence="ECO:0000269|PubMed:10644419,
FT                   ECO:0000269|PubMed:9171831"
FT                   /id="VAR_003834"
FT   VARIANT         137
FT                   /note="A -> P (in MECD1; dbSNP:rs58038639)"
FT                   /evidence="ECO:0000269|PubMed:12543196"
FT                   /id="VAR_031395"
FT   VARIANT         140
FT                   /note="L -> Q (in MECD1)"
FT                   /evidence="ECO:0000269|PubMed:24099278"
FT                   /id="VAR_072071"
FT   VARIANT         140
FT                   /note="L -> R (in MECD1; dbSNP:rs58918655)"
FT                   /evidence="ECO:0000269|PubMed:9399908"
FT                   /id="VAR_008527"
FT   VARIANT         143
FT                   /note="V -> L (in MECD1; dbSNP:rs58343600)"
FT                   /evidence="ECO:0000269|PubMed:18245975,
FT                   ECO:0000269|PubMed:9171831"
FT                   /id="VAR_003835"
FT   VARIANT         248
FT                   /note="D -> N (in MECD1; unknown pathological significance;
FT                   dbSNP:rs150674571)"
FT                   /evidence="ECO:0000269|PubMed:30535821"
FT                   /id="VAR_083314"
FT   VARIANT         399
FT                   /note="L -> LISNLEAQLL (in MECD1)"
FT                   /id="VAR_031396"
FT   VARIANT         426
FT                   /note="I -> S (in MECD1; dbSNP:rs59350319)"
FT                   /evidence="ECO:0000269|PubMed:16352477"
FT                   /id="VAR_031397"
FT   VARIANT         426
FT                   /note="I -> V (in MECD1; unknown pathological significance;
FT                   dbSNP:rs59465138)"
FT                   /evidence="ECO:0000269|PubMed:10612503"
FT                   /id="VAR_083315"
FT   VARIANT         429
FT                   /note="Y -> C (in MECD1; dbSNP:rs59202432)"
FT                   /evidence="ECO:0000269|PubMed:16227835"
FT                   /id="VAR_031398"
FT   VARIANT         429
FT                   /note="Y -> D (in MECD1; dbSNP:rs58162394)"
FT                   /evidence="ECO:0000269|PubMed:9399908"
FT                   /id="VAR_008528"
FT   VARIANT         430
FT                   /note="R -> P (in MECD1; dbSNP:rs62635290)"
FT                   /evidence="ECO:0000269|PubMed:17653038"
FT                   /id="VAR_072072"
FT   VARIANT         433
FT                   /note="L -> R (in MECD1; dbSNP:rs267607386)"
FT                   /evidence="ECO:0000269|PubMed:18661274"
FT                   /id="VAR_072073"
SQ   SEQUENCE   494 AA;  53511 MW;  75C981380532B682 CRC64;
     MDLSNNTMSL SVRTPGLSRR LSSQSVIGRP RGMSASSVGS GYGGSAFGFG ASCGGGFSAA
     SMFGSSSGFG GGSGSSMAGG LGAGYGRALG GGSFGGLGMG FGGSPGGGSL GILSGNDGGL
     LSGSEKETMQ NLNDRLASYL DKVRALEEAN TELENKIREW YETRGTGTAD ASQSDYSKYY
     PLIEDLRNKI ISASIGNAQL LLQIDNARLA AEDFRMKYEN ELALRQGVEA DINGLRRVLD
     ELTLTRTDLE MQIESLNEEL AYMKKNHEDE LQSFRVGGPG EVSVEMDAAP GVDLTRLLND
     MRAQYETIAE QNRKDAEAWF IEKSGELRKE ISTNTEQLQS SKSEVTDLRR AFQNLEIELQ
     SQLAMKKSLE DSLAEAEGDY CAQLSQVQQL ISNLEAQLLQ VRADAERQNV DHQRLLNVKA
     RLELEIETYR RLLDGEAQGD GLEESLFVTD SKSQAQSTDS SKDPTKTRKI KTVVQEMVNG
     EVVSSQVQEI EELM
//
